Description and Brand Names
US Brand Name
- Myalept
Descriptions
Metreleptin injection is used together with a proper diet as replacement therapy to treat problems caused by leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
This medicine is only available under a restricted distribution program called Myalept™ REMS program.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2019
Copyright © 2019 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.